Pharma stock jumps after receiving approval from China’s NMPA for Tacrolimus capsules

One of the pharmaceutical stocks engaged in the manufacturing of biotechnology products and research services. The stock is in focus after receiving approval from China’s National Medical Products Administration (NMPA) for Tacrolimus capsules  Stock Price Movement In Friday’s trading session, Biocon Limited’s share jumped to an intraday high of 1.18 percent from the previous close … Continue reading Pharma stock jumps after receiving approval from China’s NMPA for Tacrolimus capsules